These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

894 related articles for article (PubMed ID: 18198270)

  • 1. A meta-analytic review of psychosocial interventions for substance use disorders.
    Dutra L; Stathopoulou G; Basden SL; Leyro TM; Powers MB; Otto MW
    Am J Psychiatry; 2008 Feb; 165(2):179-87. PubMed ID: 18198270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial treatment for opiate abuse and dependence.
    Mayet S; Farrell M; Ferri M; Amato L; Davoli M
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004330. PubMed ID: 15744796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of patients with substance use disorders, second edition. American Psychiatric Association.
    Kleber HD; Weiss RD; Anton RF; George TP; Greenfield SF; Kosten TR; O'Brien CP; Rounsaville BJ; Strain EC; Ziedonis DM; Hennessy G; Connery HS; McIntyre JS; Charles SC; Anzia DJ; Cook IA; Finnerty MT; Johnson BR; Nininger JE; Summergrad P; Woods SM; Yager J; Pyles R; Cross CD; Peele R; Shemo JP; Lurie L; Walker RD; Barnovitz MA; Gray SH; Saxena S; Tonnu T; Kunkle R; Albert AB; Fochtmann LJ; Hart C; Regier D; ; ;
    Am J Psychiatry; 2007 Apr; 164(4 Suppl):5-123. PubMed ID: 17569411
    [No Abstract]   [Full Text] [Related]  

  • 5. State of the art treatments for cannabis dependence.
    Danovitch I; Gorelick DA
    Psychiatr Clin North Am; 2012 Jun; 35(2):309-26. PubMed ID: 22640758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contingency management for substance use disorders in Spain: Implications for research and practice.
    Secades-Villa R; García-Rodríguez O; Fernández-Hermida JR
    Prev Med; 2015 Nov; 80():82-8. PubMed ID: 26164071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders.
    Knapp WP; Soares BG; Farrel M; Lima MS
    Cochrane Database Syst Rev; 2007 Jul; (3):CD003023. PubMed ID: 17636713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motivation and Contingency Management Treatments for Substance Use Disorders.
    Walter KN; Petry NM
    Curr Top Behav Neurosci; 2016; 27():569-81. PubMed ID: 25762429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tobacco use and illicit substance use disorders: what should we have to do?].
    Karila L; Petit A; Zarmdini R; Coscas S; Lowenstein W; Reynaud M
    Presse Med; 2013 May; 42(5):795-805. PubMed ID: 23528335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychosocial Treatment of Addictive Disorders--An Overview of Psychotherapeutic Options and their Efficacy].
    Walter M; Dürsteler KM; Petitjean SA; Wiesbeck GA; Euler S; Sollberger D; Lang UE; Vogel M
    Fortschr Neurol Psychiatr; 2015 Apr; 83(4):201-10. PubMed ID: 25893493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in treatment outcome between male alcohol dependent offenders of domestic violence with and without positive drug screens.
    Easton CJ; Mandel D; Babuscio T; Rounsaville BJ; Carroll KM
    Addict Behav; 2007 Oct; 32(10):2151-63. PubMed ID: 17367953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries.
    Humeniuk R; Ali R; Babor T; Souza-Formigoni ML; de Lacerda RB; Ling W; McRee B; Newcombe D; Pal H; Poznyak V; Simon S; Vendetti J
    Addiction; 2012 May; 107(5):957-66. PubMed ID: 22126102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regardless of psychiatric severity the addition of contingency management to standard treatment improves retention and drug use outcomes.
    Weinstock J; Alessi SM; Petry NM
    Drug Alcohol Depend; 2007 Mar; 87(2-3):288-96. PubMed ID: 17005329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-review on the efficacy of psychological therapies for the treatment of substance use disorders.
    Dellazizzo L; Potvin S; Giguère S; Landry C; Léveillé N; Dumais A
    Psychiatry Res; 2023 Aug; 326():115318. PubMed ID: 37356250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral couples therapy (BCT) for alcohol and drug use disorders: a meta-analysis.
    Powers MB; Vedel E; Emmelkamp PM
    Clin Psychol Rev; 2008 Jul; 28(6):952-62. PubMed ID: 18374464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Working memory impairment in cannabis- and opioid-dependent adolescents.
    Vo HT; Schacht R; Mintzer M; Fishman M
    Subst Abus; 2014; 35(4):387-90. PubMed ID: 25148203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contingency management: utility in the treatment of drug abuse disorders.
    Stitzer ML; Vandrey R
    Clin Pharmacol Ther; 2008 Apr; 83(4):644-7. PubMed ID: 18305456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine abusers with and without alcohol dependence respond equally well to contingency management treatments.
    Rash CJ; Alessi SM; Petry NM
    Exp Clin Psychopharmacol; 2008 Aug; 16(4):275-81. PubMed ID: 18729681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based psychosocial treatments for adolescent substance abuse.
    Waldron HB; Turner CW
    J Clin Child Adolesc Psychol; 2008 Jan; 37(1):238-61. PubMed ID: 18444060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological and psychosocial interventions for cannabis use disorders].
    Budney AJ; Vandrey RG; Stanger C
    Braz J Psychiatry; 2010 May; 32 Suppl 1(0 1):S46-55. PubMed ID: 20512270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.